Reply to: "External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs"

J Hepatol. 2021 Apr;74(4):996-997. doi: 10.1016/j.jhep.2021.01.005. Epub 2021 Jan 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C, Chronic* / drug therapy
  • Humans
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / etiology
  • Risk Factors